Table 1.
# survey participants | Orthopaedic surgeon leadership group | Orthopaedic surgeons (AAOS outcomes SIG/ORS group) |
---|---|---|
N = 18 | N = 69 | |
% malea | 100% | 78% |
Age categorya | ||
18–24 | 0% | 0% |
25–34 | 0% | 1% |
35–44 | 0% | 17% |
45–54 | 33% | 17% |
55–64 | 67% | 41% |
65–74 | 0% | 19% |
≥75 | 0% | 4% |
Backgroundb | ||
Arthroplasty surgeon, private practice | 56% | 18% |
Arthroplasty surgeon, academic practice | 39% | 43% |
Arthroplasty researcher | 11% | 49% |
Orthopaedic surgeon, not focused on arthroplasty, private practice | 11% | 8% |
Orthopaedic surgeon, not focused on arthroplasty, academic practice | 17% | 7% |
Patient | 0% | 7% |
Policy maker | 0% | 3% |
Time spent planning/conducting arthroplasty trials | ||
0–10% | 67% | 57% |
11–20% | 28% | 16% |
21–30% | 0% | 16% |
31–50% | 0% | 4% |
>50% | 6% | 6% |
Years practicing/doing research in arthroplasty | ||
< 5 | 6% | 4% |
5–<10 | 0% | 13% |
10–20 | 18% | 23% |
>20 | 77% | 59% |
aMissing values for AAOS-Outcome SIG and OMERACT cohorts: sex: 5 vs. none; age, 4 vs. none; bBackground, people could choose more than one option